The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Anti-Inflammatory Drugs Market Between 2026 And 2030?
The anti-inflammatory drugs market has experienced substantial growth in recent years. This market is projected to expand from $152.08 billion in 2025 to $168.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. The expansion observed in prior periods is attributable to factors such as arthritis prevalence, NSAID usage, hospital prescribing practices, the increasing burden of autoimmune diseases, and the widespread adoption of steroid therapy.
The anti-inflammatory drugs market size is anticipated to experience substantial expansion in the upcoming years. It is projected to reach $252.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed during this forecast period can be linked to advancements such as biologic innovation, increased biosimilar penetration, an aging global population, the rising prevalence of autoimmune diseases, and the embrace of precision medicine. Prominent trends for the forecast period include the expanding utilization of biologics and biosimilars, a wider array of chronic inflammatory disease treatments, a pivot towards more targeted anti-inflammatory therapies, the growth of topical and localized drug formulations, and an intensified focus on long-term safety aspects.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp
What Key Factors Are Shaping The Anti-Inflammatory Drugs Market Landscape?
The increasing occurrence of arthritis is projected to boost expansion within the anti-inflammatory drugs market moving ahead. Arthritis is characterized by the inflammation of one or more joints, leading to pain, swelling, and stiffness that may intensify over time. This rise in arthritis cases is largely attributed to aging demographics; as individuals age, the natural deterioration of joints advances, significantly raising the probability of developing the condition. Anti-inflammatory medications assist in managing arthritis by alleviating joint inflammation and discomfort, thereby enabling patients to sustain improved mobility and execute everyday tasks more comfortably, consequently enhancing their overall quality of life. For example, data from July 2024, provided by Restored CDC, a US-based nonprofit health information organization, showed that approximately 21.2% of adults aged 18 and older in the US had an arthritis diagnosis in 2023. Consequently, the growing incidence of arthritis is a key factor propelling the expansion of the anti-inflammatory drugs market.
How Are Different Segments Classified In The Anti-Inflammatory Drugs Market Segment Analysis?
The anti-inflammatory drugs market covered in this report is segmented –
1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
2) By Route of Administration: Parenteral, Oral, Topical, Inhalation
3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids, Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
What Trends Are Affecting The Growth Of The Anti-Inflammatory Drugs Market?
Key companies in the anti-inflammatory drugs market are concentrating on developing innovative solutions, such as next-generation corticosteroid alternatives, to satisfy the increasing demand for safer long-term anti-inflammatory treatments. These next-generation corticosteroid alternatives are therapies engineered to maintain glucocorticoid anti-inflammatory effects while minimizing adverse outcomes often linked with traditional steroids, including bone loss, growth suppression, and weight gain. As an illustration, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, obtained US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to deliver anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to conventional corticosteroids such as prednisone and deflazacort, it provides a more favorable safety profile while preserving therapeutic benefits. It is used for the management of chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.
Who Are The Companies Driving Activity In The Anti-Inflammatory Drugs Market?
Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited
Get The Full Anti-Inflammatory Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report
Which Region Is The Leading Market For The Anti-Inflammatory Drugs Market?
North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Anti-Inflammatory Drugs Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report
Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company
Rheumatology Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model